UTILITY OF CAPDETECT™ PCA3 SCORE WITH OTHER FACTORS TO IMPROVE PREDICTION OF PROSTATE BIOPSY OUTCOME

被引：0
|
作者：
Amberson, James B.
Blase, Amy
Cochran, James S.
Groskopf, Jack
Harper, William M., IV
Johnston, William G., Jr.
Kella, Naveen
Koziol, Isaac
Patsias, Georgis
Rabin, Mark
Rittenhouse, Harry
Williams, Thomas H.
Weber, Art
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)62265-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2243
引用
收藏
页码：812 / 812
页数：1
相关论文
共 50 条
  • [1] The PCA3 score is independent of prostate gland volume, and can synergize with other patient information for predicting biopsy outcome
    Groskopf, Jack
    Deras, Ina L.
    Blase, Amy
    Aubin, Sheila M. J.
    Koo, Seongjoon
    Fradet, Yves
    Marks, Leonard S.
    Rittenhouse, Harry
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 568 - 568
  • [2] The PCA3 score is independent of prostate gland volume, and can synergize with other patient information for predicting biopsy outcome
    Groskopf, J.
    Blase, A.
    Koo, S.
    Deras, I. L.
    Aubin, S. M. J.
    Marks, L.
    Fradet, Y.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 48 - 48
  • [3] Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
    Wu, A. K.
    Reese, A. C.
    Cooperberg, M. R.
    Sadetsky, N.
    Shinohara, K.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (01) : 100 - 105
  • [4] Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
    A K Wu
    A C Reese
    M R Cooperberg
    N Sadetsky
    K Shinohara
    [J]. Prostate Cancer and Prostatic Diseases, 2012, 15 : 100 - 105
  • [5] IMPROVED PREDICTION OF BIOPSY OUTCOME USING PROSTATE CANCER GENE 3 (PCA3) IN MEN UNDERGOING AN INITIAL BIOPSY
    De La Taille, A.
    Irani, J.
    De Reijke, T.
    Haese, A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 193 - 193
  • [6] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Jose Rubio-Briones
    Angel Borque
    Luis M. Esteban
    Juan Casanova
    Antonio Fernandez-Serra
    Luis Rubio
    Irene Casanova-Salas
    Gerardo Sanz
    Jose Domínguez-Escrig
    Argimiro Collado
    Alvaro Gómez-Ferrer
    Inmaculada Iborra
    Miguel Ramírez-Backhaus
    Francisco Martínez
    Ana Calatrava
    Jose A. Lopez-Guerrero
    [J]. BMC Cancer, 15
  • [7] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Rubio-Briones, Jose
    Borque, Angel
    Esteban, Luis M.
    Casanova, Juan
    Fernandez-Serra, Antonio
    Rubio, Luis
    Casanova-Salas, Irene
    Sanz, Gerardo
    Dominguez-Escrig, Jose
    Collado, Argimiro
    Gomez-Ferrer, Alvaro
    Iborra, Inmaculada
    Ramirez-Backhaus, Miguel
    Martinez, Francisco
    Calatrava, Ana
    Lopez-Guerrero, Jose A.
    [J]. BMC CANCER, 2015, 15
  • [8] PCA3: A molecular urine assay for predicting prostate biopsy outcome
    Deras, Ina L.
    Aubin, Sheila M. J.
    Blase, Amy
    Day, John R.
    Koo, Seongjoon
    Partin, Alan W.
    Ellis, William J.
    Marks, Leonard S.
    Fradet, Yves
    Rittenhouse, Harry
    Groskopf, Jack
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 1587 - 1592
  • [9] Utility of PCA3 Urine Assay in Japanese Men Undergoing Prostate Biopsy
    Ochiai, A.
    Okihara, K.
    Kamoi, K.
    Shimazui, T.
    Oikawa, T.
    Tomita, K.
    Murayama, S.
    Umekawa, T.
    Uemura, H.
    Miki, T.
    [J]. UROLOGY, 2012, 80 (03) : S102 - S103
  • [10] THE PCA3 ASSAY IMPROVES THE PREDICTION OF INITIAL BIOPSY OUTCOME AND MAY BE INDICATIVE OF PROSTATE CANCER AGGRESSIVENESS
    De La Taille, A.
    Graefen, M.
    De Reijke, T.
    Kil, P.
    Gontero, P.
    Mottaz, A.
    Irani, J.
    Haese, A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 53 - 53
12345